Modification of Parkinsonism--chronic treatment with L-dopa

MeSH terms

• Adult
• Aged
• Agranulocytosis / chemically induced
• Aromatic Amino Acid Decarboxylase Inhibitors
• Blood Urea Nitrogen
• Blood-Brain Barrier / drug effects
• Chronic Disease
• Dihydroxyphenylalanine / administration & dosage*
• Dihydroxyphenylalanine / adverse effects
• Dihydroxyphenylalanine / metabolism
• Dihydroxyphenylalanine / toxicity
• Dihydroxyphenylalanine / urine
• Dopamine / urine
• Feeding and Eating Disorders / chemically induced
• Female
• Humans
• Huntington Disease / drug therapy
• Male
• Manganese / blood
• Mental Processes / drug effects
• Methyldopa / administration & dosage
• Middle Aged
• Movement Disorders / chemically induced
• Nausea / chemically induced
• Neurologic Manifestations
• Parkinson Disease / drug therapy*
• Phenylacetates / urine
• Placebos
• Thyroid Function Tests
• Tyrosine / metabolism
• Vomiting / chemically induced